Search Orphan Drug Designations and Approvals
-
Generic Name: | naltrexone |
---|---|
Date Designated: | 01/19/2010 |
Orphan Designation: | Treatment of Crohn's disease in pediatric patients |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Statera BioPharma, Inc. 2537 Research Boulevard Suite 201 Ft. Collins, Colorado 80526 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-